BOSTON--(BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced that Donna L. LaVoie, President and CEO, will be presenting at the BIO International Convention 2018 in Boston on Monday, June 4 at 1:00-2:15pm EST, in room 251, just before partnering opens.
The workshop, “How to Create Your Company Presentation in Just 15 Slides,” is based on the LHS trademarked process of your company's story in just fifteen slides. This workshop will provide real time examples to fine-tune your presentation and pitch before you present your company story. The agency’s management team is also available for meetings through the BIO partnering portal.
“It's exciting to be back, especially in our hometown in the “State of Possible,” where we have more innovation than anywhere in the world. I am honored to have been selected again this year by the 2018 BIO selection committee,” LaVoie said. “The market for “mindshare” is very competitive and it is very important for companies to create a clear and differentiated message in a fast-paced market of innovative technologies and medicine. It’s not enough to share data, companies need to tell stories within the boundaries of compliance rules.”
Hosted by Biotechnology Innovation Organization (BIO), BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
About LaVoieHealthScience
LaVoieHealthScience partners with
leading health and science brands to build value for their companies,
attract capital and reach key stakeholders through integrated
communications and marketing. The firm provides strategic
communications, investor relations and public relations to build
recognition and increase sales and value for health science innovations.
The agency has received over 30 awards over the past seven years in
recognition of the work it has done for its health and science
industry-leading clients, and is ranked among the 2017 Inc. 5000 list of
fastest growing private companies for the fourth year. In addition to
clients listed above, LaVoieHealthScience represents leaders such as
Affimed, BioAxone, Biotechnology Innovation Organization, Fusion
Pharmaceuticals, Genosco, Landos Biopharma, LEO Science Hub, Life
Sciences Corridor, NewLink Genetics, Newron Pharmaceuticals, Origenis
GmbH, PathMaker Biosystems, Prescriber's Choice, Scioto Biosciences,
Symbiotix, Triumvira Immunologics, Xontogeny LLC, and other emerging
health and science companies.
